This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 May;89(5):457-8.

doi: 10.1002/ajh.23687. Epub 2014 Mar 7.

Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014

John A Barranger¹, Roscoe O Brady, Gregory A Grabowski, Henry Mankin, Pramod K Mistry, Neal J Weinreb

Affiliations

PMID: 24488939
DOI: 10.1002/ajh.23687

Free article

Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014

John A Barranger et al. Am J Hematol. 2014 May.

Free article

. 2014 May;89(5):457-8.

doi: 10.1002/ajh.23687. Epub 2014 Mar 7.

Authors

John A Barranger¹, Roscoe O Brady, Gregory A Grabowski, Henry Mankin, Pramod K Mistry, Neal J Weinreb

Affiliation

¹ Lysosomal Storage Disease Clinical Care Network, Pittsburgh, PA.

PMID: 24488939
DOI: 10.1002/ajh.23687

No abstract available

PubMed Disclaimer

Similar articles

Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy.
Camou F, Viallard JF. Camou F, et al. Blood Cells Mol Dis. 2012 Jan 15;48(1):51-2. doi: 10.1016/j.bcmd.2011.09.005. Epub 2011 Oct 7. Blood Cells Mol Dis. 2012. PMID: 21983348 No abstract available.
Taliglucerase alfa approved for Gaucher disease.
Traynor K. Traynor K. Am J Health Syst Pharm. 2012 Jun 15;69(12):1009. doi: 10.2146/news120041. Am J Health Syst Pharm. 2012. PMID: 22644968 No abstract available.
Competing for the treasure in exceptions.
Cox TM. Cox TM. Am J Hematol. 2013 Mar;88(3):163-5. doi: 10.1002/ajh.23399. Epub 2013 Feb 9. Am J Hematol. 2013. PMID: 23400870 No abstract available.
Gaucher disease.
Mignot C, Gelot A, De Villemeur TB. Mignot C, et al. Handb Clin Neurol. 2013;113:1709-15. doi: 10.1016/B978-0-444-59565-2.00040-X. Handb Clin Neurol. 2013. PMID: 23622393 Review.
How I treat Gaucher disease.
Zimran A. Zimran A. Blood. 2011 Aug 11;118(6):1463-71. doi: 10.1182/blood-2011-04-308890. Epub 2011 Jun 13. Blood. 2011. PMID: 21670466 Review.

See all similar articles

Cited by

Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3).
Weinreb NJ, Finegold DN, Feingold E, Zeng Z, Rosenbloom BE, Shankar SP, Amato D. Weinreb NJ, et al. Orphanet J Rare Dis. 2015 May 22;10:64. doi: 10.1186/s13023-015-0280-3. Orphanet J Rare Dis. 2015. PMID: 25994334 Free PMC article.
The Clinical Efficacy of Imiglucerase versus Eliglustat in Patients with Gaucher's Disease Type 1: A Systematic Review.
Nabizadeh A, Amani B, Kadivar M, Toroski M, Asl AA, Bayazidi Y, Mojahedian M, Davari M. Nabizadeh A, et al. J Res Pharm Pract. 2018 Oct-Dec;7(4):171-177. doi: 10.4103/jrpp.JRPP_18_24. J Res Pharm Pract. 2018. PMID: 30622983 Free PMC article. Review.
Healthcare resource utilization and cost of care for Gaucher patients in Iran.
Davari M, Nabizadeh A, Kadivar M, Asl AA, Sarkheil P. Davari M, et al. J Diabetes Metab Disord. 2019 Apr 9;18(1):127-132. doi: 10.1007/s40200-019-00399-x. eCollection 2019 Jun. J Diabetes Metab Disord. 2019. PMID: 31275883 Free PMC article.
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center.
Basiri M, Ghaffari ME, Ruan J, Murugesan V, Kleytman N, Belinsky G, Akhavan A, Lischuk A, Guo L, Klinger K, Mistry PK. Basiri M, et al. Elife. 2023 May 30;12:e87537. doi: 10.7554/eLife.87537. Elife. 2023. PMID: 37249220 Free PMC article.
Stability is maintained in adults with Gaucher disease type 1 switched from velaglucerase alfa to eliglustat or imiglucerase: A sub-analysis of the eliglustat ENCORE trial.
Pleat R, Cox TM, Burrow TA, Giraldo P, Goker-Alpan O, Rosenbloom BE, Croal LR, Underhill LH, Gaemers SJ, Peterschmitt MJ. Pleat R, et al. Mol Genet Metab Rep. 2016 Sep 30;9:25-28. doi: 10.1016/j.ymgmr.2016.08.009. eCollection 2016 Dec. Mol Genet Metab Rep. 2016. PMID: 27722092 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information